Understanding the migration of cancer cellsJune 23, 2008Activity of regulatory proteins for the growth of filopodia and lamelopodia clarified Lamellipodia are veil-shaped protrusions of the plasma membrane, that can turn into upward-curled ruffles if they fail to adhere to the substrate. A dendritic meshwork of short and highly branched actin filaments might constitute their main structural component. The other type of protrusion, the filopodia, are finger-like and consist of parallel, long and unbranched actin filaments. Interestingly, fast-crawling cells mainly form lamellipodia/ruffles while poorly migrating or non-motile cells often show the coexistence of both lamellipodial and filopodial protrusions. These observations suggest that the lamellipodia-to-filopodia selection might regulate cell migration. Moreover, the pivotal contribution of lamellipodial and filopodial protrusions to important developmental and homeostatic processes certainly requires tight regulatory mechanisms. Unfortunately, while the microscopic morphology, dynamic development and protein signature of both lamellipodia/ruffles and filopodia have been investigated, little is known about the mechanisms whereby cells co-ordinate these actin-based extensions. Therefore, we urgently need to better understand this basic process to ultimately increase our therapeutic intervention arsenal against the metastatic progression of cancers.
It is known that the activity of regulatory proteins for the growth of the actin cytoskeleton Arp2/3 complex along with WAVE and mDia2 produce a burst of actin polymerization required for the formation of lamellipodia/ruffles and filopodia, respectively. In the forthcoming issue of Nature Cell Biology Metello Innocenti and coworkers report that, starting from the unexpected observation that mDia2, WAVE and Arp2/3 form a complex, they discovered how filopodia extensions are generated and integrated with lamellipodia/ruffles in human cancer cells. At the molecular level, WAVE and Arp2/3 jointly promote lamellipodia/ruffles outgrowth and cell migration and at the same time inhibit mDia2-dependent filopodia formation. Moreover, emission of filopodia occurs only after the disassembly of the mDia2-WAVE-Arp2/3 complex. Thus, it is likely that suppression of filopodia by the ruffling-making machinery is needed for cancer cells to move efficiently. Their results pave the way to a cogent molecular analysis of the interplay between lamellipodia/ruffles and filopodia in regulating both the migratory and invasive abilities of cancer cells. The researchers anticipate that new and more specific therapies to counteract cancer will be developed exploiting these exciting findings. Goethe University Frankfurt | |||||||||||||||||||||
|
Related Cancer Cells News Articles New role for Natural Killers! Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer. Variation of normal protein could be key to resistance to common cancer drug Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug. Normalizing tumor vessels to improve cancer therapy Chemotherapy drugs often never reach the tumors they're intended to treat, and radiation therapy is not always effective, because the blood vessels feeding the tumors are abnormal-"leaky and twisty" in the words of the late Judah Folkman, MD, founder of the Vascular Biology program at Children's Hospital Boston. Dense tissue promotes aggressive cancers New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology. UAB Anti-Cancer Research Featured in Scientific American Scientific American magazine focused on two University of Alabama at Birmingham (UAB) Comprehensive Cancer Center researchers in a news story on experimental next-generation anti-cancer therapies. Why a common treatment for prostate cancer ultimately fails Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences. Drugs to inhibit blood vessel growth show promise in rat model of deadly brain tumor In a landmark study, Medical College of Wisconsin researchers in Milwaukee report that drugs used to inhibit a specific fatty acid in rat brains with glioblastoma-like tumors not only reduced new blood vessel growth and tumor size dramatically, but also prolonged survival. The study is the featured cover story of the August, 2008 Journal of Cerebral Blood Flow & Metabolism. Researchers discover how rheumatoid arthritis causes bone loss Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. Study shows how daughter is different from mother The mother-daughter relationship can be difficult to understand. Why are the two so different? Now a Northwestern University study shows how this happens. In yeast cells, that is. New method to overcome multiple drug resistant diseases developed by Stanford researchers Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them. More Cancer Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||